UBS Group’s Aclarion ACON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.5K Buy
9,647
+8,597
+819% +$29.4K ﹤0.01% 7653
2025
Q4
$4.83K Buy
+1,050
New +$7.29K ﹤0.01% 8772
2025
Q3
Sell
-1,729
Closed -$13K 10283
2025
Q2
$13K Buy
1,729
+1,677
+3,225% +$12.8K ﹤0.01% 8714
2025
Q1
$562 Buy
+52
New +$16.2K ﹤0.01% 9736
2024
Q4
Sell
-4
Closed -$7.32K 9871
2024
Q3
$7.32K Hold
4
﹤0.01% 7915
2024
Q2
$11.4K Buy
+4
New +$11K ﹤0.01% 7642
2023
Q4
Hold
0
-$44 9230
2023
Q3
Hold
0
9027
2023
Q2
Hold
0
-$4.66K 8821
2023
Q1
Hold
0
8162
2022
Q4
Hold
0
10007
2022
Q3
Hold
0
8685
2022
Q2
Hold
0
8443

Other funds holding ACON

UBS Group's ACON Position: Q1 2026 in Review

UBS Group increased its Aclarion (ACON) stake by 819% in Q1 2026, buying an estimated $29.4K and bringing the position to 9,647 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7653.

UBS Group first reported a position in ACON in Q2 2024 and has held it in 6 quarters since. 10 funds tracked by Wall St. Rank hold ACON as of Q1 2026.

  • UBS Group held 9,647 shares of Aclarion worth $31.5K as of Q1 2026.
  • UBS Group bought 8,597 Aclarion shares in Q1 2026, an estimated $29.4K.
  • Aclarion made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7653 holding.
  • UBS Group first reported a position in Aclarion in Q2 2024 and has held it in 6 quarters since.
  • 10 funds tracked by Wall St. Rank held Aclarion as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.